Skip to main content
. 2019 Jun 17;8(6):178. doi: 10.3390/antiox8060178

Table 4.

Effect of Ochratoxin A on malondialdehyde content in liver and kidney homogenates (mean ± SD; n = 6).

Malondialdehyde in Liver Homogenate (μmol/g Wet Weight Tissue)
Day 0 Day 7 Day 14 Day 21
Control 64.46 ± 11.23 49.89 ± 6.49 a 43.71 ± 14.24 a 58.21 ± 5.89 a
O1 57.21 ± 11.54 ab 59.83 ± 7.31 ab 61.54 ± 14.95 ab
O2 56.79 ± 13.57 ab 62.34 ± 15.11 ab 56.53 ± 9.91 a
O3 77.59 ± 28.07 b 74.28 ± 18.64 b 77.41 ± 8.39 b
Malondialdehyde in Kidney Homogenate (μmol/g Wet Weight Tissue)
Day 0 Day 7 Day 14 Day 21
Control 36.32 ± 10.10 41.11 ± 7.98 a 41.03 ± 12.27 46.19 ± 5.37
O1 42.38 ± 9.19 ab 42.55 ± 12.39 44.14 ± 2.67
O2 46.25 ± 11.94 ab 43.65 ± 9.19 41.32 ± 9.68
O3 57.93 ± 7.44 b 50.75 ± 8.14 45.23 ± 3.08

a,b Different superscripts in the same column mean significant difference at p < 0.05 level. O1: 106 μg OTA/kg feed, O2: 654 μg OTA/kg feed, O3: 1126 μg OTA/kg feed.